Announcements Trials
Browse Landscape

Phase

Phase 1 4

Status

Completed 4

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 33Thoracic 27Gastrointestinal 27Gynecologic 11Head & Neck 10Genitourinary 10Breast 8Dermatologic 6CNS 5Lymphoid 4Sarcoma 3Other solid neoplasm 3Endocrine 2Plasma cell 1Other 1Classical hematology 1

Conditions

Lymphoma 41Lymphoma, Large B-Cell, Diffuse 31Lymphoma, Non-Hodgkin 28Lymphoma, Follicular 21Lymphoma, Large-Cell, Immunoblastic 17Hodgkin Disease 16Lymphoma, Mantle-Cell 15Burkitt Lymphoma 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Leukemia, Lymphocytic, Chronic, B-Cell 9Recurrence 8Lymphoma, Large-Cell, Anaplastic 8Lymphoma, B-Cell, Marginal Zone 6Waldenstrom Macroglobulinemia 5Lymphoma, B-Cell 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Neoplasms 4Lymphoma, Extranodal NK-T-Cell 4Immunoblastic Lymphadenopathy 4Neoplasm Metastasis 3Lymphoma, T-Cell, Peripheral 3Lymphoma, T-Cell, Cutaneous 3Mesothelioma 2Lymphoma, T-Cell 2Leukemia 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Uveal Melanoma 1Sezary Syndrome 1Primary Myelofibrosis 1

Interventions

Cyclophosphamide 35Rituximab 33venetoclax 24ibrutinib 14Vincristine 14Prednisone 14Doxorubicin 14Gemcitabine 13pembrolizumab 12fludarabine 12Bendamustine Hydrochloride 11Etoposide 10obinutuzumab 9Filgrastim 9Dexamethasone 9Bortezomib 9fludarabine phosphate 8Mycophenolic Acid 8Drug Therapy 8ofatumumab 7Whole-Body Irradiation 7Sirolimus 7Peripheral Blood Stem Cell Transplantation 7Methotrexate 7Busulfan 7Therapeutics 6Radiotherapy 6Mesna 6Lenalidomide 6Ipilimumab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Neoplasms × Cisplatin × Lymphoid × Clear all
NCT03013218 2025-08-01

A Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01)

ALX Oncology Inc.

Phase 1 Completed
174 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, Neoplasm Metastasis, Neoplasms

NCT03027284 2020-05-19

A Study of Merestinib (LY2801653) in Japanese Participants With Advanced or Metastatic Cancer

Eli Lilly and Company

Phase 1 Completed
19 enrolled
GastrointestinalLymphoid

Gallbladder Neoplasms, Lymphoma, Non-Hodgkin, Neoplasm Metastasis, Neoplasms, Cholangiocarcinoma

NCT00705874 2016-07-21

Study of CGC-11047 When Used in Individual Combinations With 1) Gemcitabine or 2) Docetaxel or 3) Bevacizumab or 4) Erlotinib or 5) Cisplatin or 6) 5-Flurouracil or 7) Sunitinib in Patients With Advanced Solid Tumors or Lymphoma

Progen Pharmaceuticals

Phase 1 Completed
172 enrolled 13 charts
Lymphoid

Lymphoma, Neoplasms

NCT01345357 2013-01-18

Study of CEP-9722 in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors or Mantle Cell Lymphoma

Teva Branded Pharmaceutical Products R&D, Inc.

Phase 1 Completed
24 enrolled
Lymphoid

Neoplasms, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡